380 related articles for article (PubMed ID: 21822176)
1. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
Albalat A; Mischak H; Mullen W
Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of urinary proteomics/peptidomics.
Albalat A; Mischak H; Mullen W
Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
[TBL] [Abstract][Full Text] [Related]
3. Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.
Metzger J; Schanstra JP; Mischak H
Anal Bioanal Chem; 2009 Mar; 393(5):1431-42. PubMed ID: 18704377
[TBL] [Abstract][Full Text] [Related]
4. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
5. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
6. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
Stepczynska A; Schanstra JP; Mischak H
Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
[TBL] [Abstract][Full Text] [Related]
7. Urine as a source for clinical proteome analysis: from discovery to clinical application.
Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
[TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
Fliser D; Wittke S; Mischak H
Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
[TBL] [Abstract][Full Text] [Related]
9. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
10. Capillary electrophoresis interfaced with a mass spectrometer (CE-MS): technical considerations and applicability for biomarker studies in animals.
Albalat A; Husi H; Siwy J; Nally JE; McLauglin M; Eckersall PD; Mullen W
Curr Protein Pept Sci; 2014 Feb; 15(1):23-35. PubMed ID: 24555889
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
12. Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.
Pejchinovski M; Hrnjez D; Ramirez-Torres A; Bitsika V; Mermelekas G; Vlahou A; Zürbig P; Mischak H; Metzger J; Koeck T
Proteomics Clin Appl; 2015 Jun; 9(5-6):453-68. PubMed ID: 25641766
[TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery in mass spectrometry-based urinary proteomics.
Thomas S; Hao L; Ricke WA; Li L
Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
15. Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
Metzger J; Luppa PB; Good DM; Mischak H
Crit Rev Clin Lab Sci; 2009; 46(3):129-52. PubMed ID: 19404829
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based proteomics in urine biomarker discovery.
Theodorescu D; Mischak H
World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
[TBL] [Abstract][Full Text] [Related]
17. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
Zürbig P; Schiffer E; Mischak H
Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
[TBL] [Abstract][Full Text] [Related]
18. Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.
Albalat A; Husi H; Stalmach A; Schanstra JP; Mischak H
Bioanalysis; 2014 Jan; 6(2):247-66. PubMed ID: 24423599
[TBL] [Abstract][Full Text] [Related]
19. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
[TBL] [Abstract][Full Text] [Related]
20. Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future.
Latosinska A; Siwy J; Mischak H; Frantzi M
Electrophoresis; 2019 Sep; 40(18-19):2294-2308. PubMed ID: 31054149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
